Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
As Clearside prepares to transition from a clinical-stage to a commercial-stage company, Mr. Rodríguez will be responsible for ensuring that the company continues to design and implement appropriate programs, policies and procedures related to quality assurance and quality control activities across the company and its suppliers. He will also provide cross-functional compliance oversight of activities involving all recognized quality standards for the pharmaceutical industry, such as good manufacturing practices and good clinical practices.
Mr. Rodríguez is an accomplished quality management professional with over 30 years of experience in the pharmaceuticals industry. Before joining Clearside, Mr. Rodríguez was Vice President of Quality for
“Lester is a seasoned quality leader who brings to Clearside a wealth of experience and expertise in pharmaceutical quality assurance, quality control, and quality systems management,” said Clearside’s Chief Executive Officer and President,
Cautionary Note Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe”, “expect”, “may”, “plan”, “potential”, “will”, and similar expressions, and are based on Clearside’s current beliefs and expectations. These forward-looking statements include expectations regarding the clinical development of Clearside’s product candidates, the timing of a potential submission of an NDA with the
Chief Financial Officer
Source: Clearside Biomedical, Inc.